Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 21-Feb-24 4:04 PM View:  | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Payment of Exercise | 1,509 | $37.21 | $56,149.90 | (< 1%) 1.23M to 1.23M | |
| 21-Feb-24 4:04 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Option Exercise | 3,760 | -- | -- | < 1% 1.23M to 1.23M | |
| 20-Nov-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Payment of Exercise | 1,301 | $28.86 | $37,546.90 | (< 1%) 1.23M to 1.23M | |
| 20-Nov-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Option Exercise | 3,760 | -- | -- | < 1% 1.22M to 1.23M | |
| 18-Aug-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-23 | Payment of Exercise | 1,301 | $29.80 | $38,769.80 | (< 1%) 1.23M to 1.22M | |
| 18-Aug-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-23 | Option Exercise | 3,760 | -- | -- | < 1% 1.22M to 1.23M | |
| 18-May-23 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-23 | Payment of Exercise | 1,300 | $14.09 | $18,317.00 | (< 1%) 1.22M to 1.22M | |
| 18-May-23 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-23 | Option Exercise | 3,759 | -- | -- | < 1% 1.22M to 1.22M | |
| 21-Feb-23 8:18 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-23 | Payment of Exercise | 1,534 | $12.64 | $19,389.80 | (< 1%) 1.22M to 1.22M | |
| 21-Feb-23 8:18 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-23 | Option Exercise | 3,760 | -- | -- | < 1% 1.22M to 1.22M | |
| 18-Nov-22 6:36 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-22 | Payment of Exercise | 1,301 | $9.64 | $12,541.60 | (< 1%) 1.22M to 1.21M | |
| 18-Nov-22 6:36 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-22 | Option Exercise | 3,760 | -- | -- | < 1% 1.21M to 1.22M | |
| 18-Aug-22 6:33 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-22 | Payment of Exercise | 1,287 | $11.08 | $14,260.00 | (< 1%) 1.21M to 1.21M | |
| 18-Aug-22 6:33 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-22 | Option Exercise | 3,760 | -- | -- | < 1% 1.21M to 1.21M | |
| 18-May-22 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-22 | Payment of Exercise | 1,541 | $6.74 | $10,386.30 | (< 1%) 1.21M to 1.21M | |
| 18-May-22 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-May-22 | Option Exercise | 3,759 | -- | -- | < 1% 1.2M to 1.21M | |
| 03-Mar-21 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 01-Mar-21 | Grant | 1,521 | -- | -- | < 1% 1.2M to 1.21M | |
| 03-Mar-21 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 01-Mar-21 | Payment of Exercise | 524 | $71.91 | $37,680.80 | (< 1%) 1.21M to 1.2M | |
| 19-Oct-20 9:14 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Oct-20 | Option Exercise | 10,256 | $17.00 | $174,352.00 | < 1% 1.2M to 1.21M | |
| 19-Oct-20 9:14 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Oct-20 | Planned Option Sale | 10,256 | $41.00 | $420,496.00 | (< 1%) 1.21M to 1.2M | |
| 01-Oct-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 30-Sep-20 | Option Exercise | 10,000 | $17.00 | $170,000.00 | < 1% 1.2M to 1.21M | |
| 01-Oct-20 4:05 PM View: | Bridgebio Pharma, Inc. (BBIO) | 30-Sep-20 | Planned Option Sale | 10,000 | $38.00 | $380,000.00 | (< 1%) 1.21M to 1.2M | |
| 29-Sep-20 7:02 PM View: | Bridgebio Pharma, Inc. (BBIO) | 29-Sep-20 | Sale (Planned) | 18,200 | $37.50 | $682,500.00 | (1%) 1.22M to 1.2M | |
| 29-Sep-20 7:02 PM View: | Bridgebio Pharma, Inc. (BBIO) | 25-Sep-20 | Sale (Planned) | 81,057 | $36.83 | $2,985,460.00 | (6%) 1.3M to 1.22M | |
| 07-Apr-20 4:06 PM View: | Bridgebio Pharma, Inc. (BBIO) | 03-Apr-20 | Gift | 40,000 | -- | -- | (3%) 1.34M to 1.3M | |
| 12-Feb-20 7:03 PM View: | Bridgebio Pharma, Inc. (BBIO) | 10-Feb-20 | Sale (Planned) | 20,000 | $36.00 | $720,000.00 | (1%) 1.36M to 1.34M | |
| 16-Jan-20 7:17 PM View: | Bridgebio Pharma, Inc. (BBIO) | 14-Jan-20 | Option Exercise | 10,000 | $17.00 | $170,000.00 | < 1% 1.36M to 1.37M | |
| 16-Jan-20 7:17 PM View: | Bridgebio Pharma, Inc. (BBIO) | 14-Jan-20 | Planned Option Sale | 10,000 | $35.00 | $350,000.00 | (< 1%) 1.37M to 1.36M | |
| 03-Jul-19 4:12 PM View: | Bridgebio Pharma, Inc. (BBIO) | 01-Jul-19 | Option Exercise | 1,361,430 | -- | -- | 100% 0 to 1.36M | |
| 04-Jan-19 5:46 PM View: | Portola Pharmaceuticals Inc (PTLA) | 02-Jan-19 | Option Exercise | 45,923 | $5.10 | $234,207.00 | 18% 251.95K to 297.87K | |
| 19-Dec-18 7:07 PM View: | Portola Pharmaceuticals Inc (PTLA) | 19-Dec-18 | Option Exercise | 25,782 | $4.10 | $105,706.00 | 11% 226.17K to 251.95K | |
| 19-Dec-18 7:07 PM View: | Portola Pharmaceuticals Inc (PTLA) | 17-Dec-18 | Option Exercise | 64,218 | $4.10 | $263,294.00 | 28% 226.17K to 290.39K | |
| 19-Dec-18 7:07 PM View: | Portola Pharmaceuticals Inc (PTLA) | 17-Dec-18 | Market Option Sale | 64,218 | $18.61 | $1,195,000.00 | (22%) 290.39K to 226.17K | (66%) |
| 16-Nov-18 5:24 PM View: | Portola Pharmaceuticals Inc (PTLA) | 14-Nov-18 | Option Exercise | 93,698 | $4.10 | $384,162.00 | 71% 132.47K to 226.17K | |
| 08-Jun-18 6:37 PM View: | Portola Pharmaceuticals Inc (PTLA) | 08-Jun-18 | Grant | 3,000 | -- | -- | 2% 132.47K to 135.47K | |
| 14-Feb-18 10:00 PM View: | Global Blood Therapeutics, ... (GBT) | 28-Nov-17 | Acquisition (other) | 6,359 | -- | -- | 7% 95.65K to 102.01K | |
| 14-Feb-18 10:00 PM View: | Global Blood Therapeutics, ... (GBT) | 21-Nov-17 | Disposition (other) | 6,359 | -- | -- | (6%) 102.01K to 95.65K | |
| 27-Oct-17 5:15 PM View: | Global Blood Therapeutics, ... (GBT) | 27-Oct-17 | Market Sale | 15,600 | $34.09 | $531,770.00 | (18%) 84.93K to 69.33K | (33%) |
| 14-Feb-18 10:00 PM View: | Global Blood Therapeutics, ... (GBT) | 26-Oct-17 | Disposition (other) | 70,000 | -- | -- | (41%) 172.01K to 102.01K | |
| 27-Oct-17 5:15 PM View: | Global Blood Therapeutics, ... (GBT) | 26-Oct-17 | Market Sale | 54,400 | $33.93 | $1,845,780.00 | (39%) 139.33K to 84.93K | (33%) |
| 05-Oct-17 5:00 PM View: | Global Blood Therapeutics, ... (GBT) | 04-Oct-17 | Sale | -- | -- | -- | 0% 139.33K | |
| 05-Oct-17 5:00 PM View: | Global Blood Therapeutics, ... (GBT) | 03-Oct-17 | Sale | -- | -- | -- | 0% 139.33K | |
| 14-Feb-18 10:00 PM View: | Global Blood Therapeutics, ... (GBT) | 26-Sep-17 | Acquisition (other) | 2,563 | -- | -- | 2% 169.45K to 172.01K | |
| 14-Feb-18 10:00 PM View: | Global Blood Therapeutics, ... (GBT) | 21-Sep-17 | Disposition (other) | 2,563 | -- | -- | (1%) 172.01K to 169.45K | |
| 14-Feb-18 10:00 PM View: | Global Blood Therapeutics, ... (GBT) | 28-Jul-17 | Acquisition (other) | 112,685 | -- | -- | 190% 59.33K to 172.01K | |
| 27-Jun-17 4:51 PM View: | Portola Pharmaceuticals Inc (PTLA) | 23-Jun-17 | Option Exercise | 120,803 | $5.00 | $604,015.00 | 100% 0 to 120.8K | |
| 27-Jun-17 4:51 PM View: | Portola Pharmaceuticals Inc (PTLA) | 23-Jun-17 | Market Option Sale | 120,803 | $53.06 | $6,409,810.00 | (100%) 120.8K to 0 | 42% |
| 14-Feb-18 10:00 PM View: | Global Blood Therapeutics, ... (GBT) | 21-Jun-17 | Acquisition (other) | 1,504 | -- | -- | 3% 57.82K to 59.33K | |
| 19-Jun-17 6:02 PM View: | Portola Pharmaceuticals Inc (PTLA) | 16-Jun-17 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 14-Feb-18 10:00 PM View: | Global Blood Therapeutics, ... (GBT) | 14-Jun-17 | Disposition (other) | 1,504 | -- | -- | (3%) 59.33K to 57.82K |